Next Article in Journal
A Comparison of Dietary Protein Digestibility, Based on DIAAS Scoring, in Vegetarian and Non-Vegetarian Athletes
Next Article in Special Issue
Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice?
Previous Article in Journal
Effect of Fibre-Enriched Orange Juice on Postprandial Glycaemic Response and Satiety in Healthy Individuals: An Acute, Randomised, Placebo-Controlled, Double-Blind, Crossover Study
Previous Article in Special Issue
Obesity in the Liver Transplant Setting
Open AccessArticle

Weight Gain and De Novo Metabolic Disorders after Liver Transplantation

1
Department of Translational and Precision medicine, Sapienza University of Rome, Italy Viale dell’Università 37, 00185 Roma, Italy
2
Department of General Surgery “Paride Stefanini”, Liver Transplantation Unit, “Sapienza” University, 00185 Rome, Italy
*
Author to whom correspondence should be addressed.
Nutrients 2019, 11(12), 3015; https://doi.org/10.3390/nu11123015
Received: 11 November 2019 / Revised: 30 November 2019 / Accepted: 5 December 2019 / Published: 10 December 2019
(This article belongs to the Special Issue Nutrition in Liver Cirrhosis and Liver Transplantation)
The development of nutritional and metabolic abnormalities represents an important burden in patients after liver transplantation (LT). Our study aimed at evaluating the incidence, time of onset, and risk factors for nutritional and metabolic abnormalities in patients after LT. The study was a single-center retrospective study. Consecutive patients undergoing elective LT from 2000 to 2016 were enrolled. The presence of at least two among arterial hypertension (AH), diabetes mellitus (DM), dyslipidemia, and obesity (BMI ≥ 30 Kg/m2) was utilized to define patients with the metabolic disorder (MD). Three hundred and fifteen patients were enrolled; the median age was 56 years (68% males). Non-alcoholic steatohepatitis (NASH) was the origin of liver disease in 10% of patients. During follow-up, 39% of patients developed AH, 18% DM, and 17% dyslipidemia. Metabolic disorders were observed in 32% of patients. The NASH etiology (OR: 6.2; CI 95% 0.5–3; p = 0.003) and a longer follow-up (OR: 1.2; CI 95% 0.004–0.02; p = 0.002) were associated with de novo MD. In conclusion, nutritional and metabolic disorders are a frequent complication after LT, being present in up to one-third of patients. The NASH etiology and a longer distance from LT are associated with de novo MD after LT. View Full-Text
Keywords: liver transplantation (LT); body mass index (BMI); metabolic disorders (MDs), non-alcoholic steatohepatitis (NASH) liver transplantation (LT); body mass index (BMI); metabolic disorders (MDs), non-alcoholic steatohepatitis (NASH)
Show Figures

Figure 1

MDPI and ACS Style

Lattanzi, B.; D’Ambrosio, D.; Tavano, D.; Pitoni, D.; Mennini, G.; Ginanni Corradini, S.; Rossi, M.; Merli, M. Weight Gain and De Novo Metabolic Disorders after Liver Transplantation. Nutrients 2019, 11, 3015.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop